Administration of high-dose intravenous immune globulin (IVIG) significantly improved muscle and joint pain, muscle weakness and markers of systemic inflammation, according to a retrospective evaluation of 46 systemic sclerosis patients at 19 French centers.
The U.S. Food and Drug Administration has approved Renflexis (infliximababda, Samsung Bioepis), the second biosimilar to Remicade (infliximab, Janssen Biotech).
Under a new rule, the Health Resources and Services Administration of the Department of Health and Human Services can issue fines of up to $5,000 for each incident to drug manufacturers that knowingly and intentionally overcharge 340B hospitals for drugs purchased under the program.
Researchers at Brigham and Women’s Hospital have discovered a subset of T cells that collaborate with other immune cells to drive inflammation in peripheral tissues.
Researchers at the Moffitt Cancer Center are developing a new vaccine that will help early-stage breast cancer patients who have HER2 positive disease.
The Centers for Medicare and Medicaid Services (CMS) issued an interim rule to delay the implementation of its bundled payment program for cardiac care, as well as for expansion of its Comprehensive Care for Joint Replacement (CJR) program.
Researchers have identified a peptide in the mucus secreted by a South Indian frog that can kill certain types of flu viruses.
Results from a new study show that brain function can be restored by human blood plasma.
A study has found that patients with type 2 diabetes have a higher prevalence of chronic hepatitis B virus infection.
The Veterans Affairs (VA) Department has issued a rule that will allow all advanced-practice registered nurses, with the exception of certified registered nurse anesthetists, to practice to their full authority at VA facilities.
Results of a Phase II clinical trial ofPfizer’s preventive vaccine againstClostridium difficile (C. diff) showed the vaccine was safe and stimulated a C. diff targeted immune response.
A study has found that patients with fibromyalgia have a high prevalence of anti-thyroid-stimulating hormone receptor antibody.
